A small biotech company, Roquefort Therapeutics, is set to enhance its portfolio through the acquisition of rights to a clinical-stage cancer treatment in a reverse takeover valued at £32 million.
All posts tagged in cancertherapy
1Article
A small biotech company, Roquefort Therapeutics, is set to enhance its portfolio through the acquisition of rights to a clinical-stage cancer treatment in a reverse takeover valued at £32 million.
